Email Us
The Trial Lawyer Magazine Logo
SUBSCRIBE

The Press Release Crime of a Biotech CEO and its Impact on Scientific Research
The Press Release Crime of a Biotech CEO and its Impact on Scientific Research

Washington Post; September 23, 2013

Is it a crime for a medical researcher to hype his results? To put a heavy spin on the findings when there are millions of dollars, and possibly lives, at stake?

Just ask W. Scott Harkonen.

“I get four hours for errands, once a week. With good behavior, that could go up to six hours,” the 61-year-old physician said recently. “I feel part of an interned population.”

Once the well-paid head of a publicly traded biotech company called InterMune, Harkonen began six months of home confinement July 1. Several times a day he gets a robo-call that checks to make sure he’s inside. His status is an embarrassment, and few people come to visit.

Of course, things could be worse. A federal prosecutor wanted him to get 10 years in prison. Instead, he got a half-year of home detention in his three-story Tudor in San Francisco. But unless his appeals are successful, he won’t ever be able to work as a pharmaceutical researcher and maybe not as a physician, either.

To read the complete article, please click here: https://www.washingtonpost.com/national/health-science/the-press-release-crime-of-a-biotech-ceo-and-its-impact-on-scientific-research/2013/09/23/9b4a1a32-007a-11e3-9a3e-916de805f65d_story.html?hpid=z12

 

Generic selectors
Exact matches only
Search in title
Search in content
The Trial Lawyer Magazine Logo
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram